Transplant and Specialty Services Network Guidelines 

Humana’s National Transplant and Specialty Services Network consists of solid organ transplants, stem cell transplants, Chimeric antigen receptor (CAR) T-cell therapy, gene therapy, Ventricular Assist Devices (VAD) and VAD supplies.  

To participate in Humana’s National Transplant and Specialty Services Network for solid organ transplants, a transplant center must be a CMS (Centers for Medicare and Medicaid Services) approved center for the specific transplant program. Also, the center must have active Organ Procurement and Transplantation Network (OPTN) membership. Both CMS and OPTN have requirements that centers must meet, such as transplant volume, graft/patient survival and other pertinent facility statistical data from the Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network.   

For Stem Cell transplants, the facility must be FACT (Foundation for the Accreditation of Cellular Therapy) accredited. FACT has a set of requirements to ensure patient safety and outcomes, such as volume of allogeneic stem cell transplants and patient survival reported by Center for International Blood & Marrow Transplant Research (CIBMTR).   

All CAR-T and gene therapy drugs must be approved by the Food and Drug Administration (FDA).   

A list of Transplant and Specialty Services Network Centers/Suppliers can be found here: National Transplant Network Locator - Humana 

Cuidado de pacientes​​

Cuidado de pacientes